Moalla 2006.

Study characteristics
Methods	Aim of study: to assess exercise tolerance, and to investigate how the 6’WT could be a useful test in the follow‐up of rehabilitation programme in children with CHD Study design: RCT Country: France
Participants	N randomised total: 18; intervention: 10; comparator: 8 intervention: mild = 3; severe = 7 comparator: mild = 1; severe = 7 Age (mean ± SD); intervention: 13.0 ± 1.4; comparator: 12.8 ± 1.3 Inclusion criteria: the left ventricle ejection fraction (LVEF) of CHD group was < 40%. All patients had undergone cardiac surgery reconstruction for complex heart disease. The CHD subjects had to be stabilized with drug treatment for at least 3 months; their medication was the same during the training period. Medical therapy included diuretics, cardiotonics, antivitamins K, and angiotensin‐converting enzyme inhibitor. Exclusion criteria: subjects with additional diagnoses of locomotor or mental disorders or other diseases that could limit muscle performance were excluded from the study. Beta‐blockers, pacemaker.
Interventions	Description: cycling 12 week intervention Setting: home Supervision: unsupervised – pulse monitors checked weekly for compliance Detail of exercise: Modality:  cycling Intensity: Hr at the VT/GET Resistance training included? No 1 ‐ Length of session: 12  weeks 2 ‐ Frequency/no. of sessions a week: 3 3 ‐ Duration of session: 60 mins Dose of exercise: 1*2*3 = 2160
Outcomes	CRF maximal and submaximal  Strength NIRS
Notes